US Patent 7592295 Farnesene dimers and/or farnesane dimers and compositions thereof
Patent 7592295 was granted and assigned to Amyris Biotechnologies on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Frank X. Woolard0
Karl Fisher0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+232 characters)
Article
Patent abstract
Farnesene dimers and/or farnesane dimers and compositions thereof are described. The compositions provided comprise conventional additives. Methods of making and using the compounds and composition are also disclosed.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07592295 Farnesene dimers and/or farnesane dimers and compositions thereof US Patent 7592295 Farnesene dimers and/or farnesane dimers and compositions thereof
Infobox
Patent Number
07592295
Patent Number
7592295
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07592295 Farnesene dimers and/or farnesane dimers and compositions thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07592295
Date of patent
September 22, 2009
Patent application number
12409437
Date Filed
March 23, 2009
Patent primary examiner
Find more entities like US Patent 7592295 Farnesene dimers and/or farnesane dimers and compositions thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
